| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78206-147-01 | 78206-147 | HUMAN PRESCRIPTION DRUG | Ontruzant | trastuzumab | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20210601 | N/A | BLA | BLA761100 | Organon LLC | TRASTUZUMAB | 150 mg/1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99) |
| 78206-148-01 | 78206-148 | HUMAN PRESCRIPTION DRUG | Ontruzant | Ontruzant | KIT | INTRAVENOUS | 20210601 | N/A | BLA | BLA761100 | Organon LLC | 1 KIT in 1 CARTON (78206-148-01) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE (78206-191-99) * 1 INJECTION, SOLUTION in 1 VIAL (78206-149-89) |